Abstract
Chagas disease (CD) and Leishmaniasis are major health problems in the Americas, being Brazil and Colombia, countries where these diseases are epidemiologically significant. Despite the important health burden of these diseases, there is little investment by pharmaceutical companies, and the governments from endemic countries assign limited resources to health care. In addition, there are…